Literature DB >> 7283409

Experimental endocarditis caused by Streptococcus sanguis: single and combined antibiotic therapy.

M V Vicente, T Olay, A Rodríguez.   

Abstract

The effectiveness of penicillin G, fosfomycin, and cefoxitin alone and in combination was studied in vitro and in the treatment of left-sided Streptococcus sanguis endocarditis in rabbits. In vitro, the combinations penicillin G plus fosfomycin, penicillin G plus cefoxitin, and fosfomycin plus cefoxitin were synergistic or partially synergistic for S sanguis. Therapy with the combinations was more effective in eradicating the species from cardiac vegetations that was that with each antibiotic used alone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283409      PMCID: PMC181623          DOI: 10.1128/AAC.20.1.10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis.

Authors:  M A Sande; R G Irvin
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

2.  Antibiotic treatment of streptococcal endocarditis.

Authors:  D Kaye
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

3.  Diffusion of beta-lactam antibiotics and fosfomycin to interstitial tissue fluid in rabbits.

Authors:  M V Vicente; T Olay; M C Quecedo; A Rodríguez
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

4.  Interaction of fosfomycin with other antimicrobial agents: in vitro and in vivo studies.

Authors:  T Olay; A Rodríguez; L E Oliver; M V Vicente; M C Quecedo
Journal:  J Antimicrob Chemother       Date:  1978-11       Impact factor: 5.790

5.  Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.

Authors:  D T Durack; L L Pelletier; R G Petersdorf
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

Review 6.  Combination antibiotic therapy of bacterial endocarditis.

Authors:  M A Sande; W M Scheld
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

7.  Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.

Authors:  J C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

8.  Chemotherapy of experimental streptococcal endocarditis. V. Effect of duration of infection and retained intracardiac catheter on response to treatment.

Authors:  L L Pelletier; R G Petersdorf; K Nielson
Journal:  J Lab Clin Med       Date:  1976-04

9.  Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.

Authors:  C Watanakunakorn; C Bakie
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

10.  Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart.

Authors:  P K Garrison; L R Freedman
Journal:  Yale J Biol Med       Date:  1970-06
  10 in total
  1 in total

1.  Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.

Authors:  A Rodríguez; M V Vicente; T Olay
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.